SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001737287-24-000034
Filing Date
2024-04-23
Accepted
2024-04-23 16:33:42
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-23

Document Format Files

Seq Description Document Type Size
1 ARS allo-20231231x10k.pdf ARS 19410072
  Complete submission text file 0001737287-24-000034.txt   26739083
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38693 | Film No.: 24865283
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)